Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial

por Cortes, Javier, Hudgens, Stacie, Twelves, Chris, Perez, Edith A., Awada, Ahmad, Yelle, Louise, McCutcheon, Susan, Kaufman, Peter A., Forsythe, Anna, Velikova, Galina
Publicado 2015

Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast...

por Sanft, Tara, Aktas, Bilge, Schroeder, Brock, Bossuyt, Veerle, DiGiovanna, Michael, Abu-Khalaf, Maysa, Chung, Gina, Silber, Andrea, Hofstatter, Erin, Mougalian, Sarah, Epstein, Lianne, Hatzis, Christos, Schnabel, Cathy, Pusztai, Lajos
Publicado 2015

Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia

por Bushinsky, David A, Williams, Gordon H, Pitt, Bertram, Weir, Matthew R, Freeman, Mason W, Garza, Dahlia, Stasiv, Yuri, Li, Elizabeth, Berman, Lance, Bakris, George L
Publicado 2015

Effects of a self-management program on antiemetic-induced constipation during chemotherapy among breast cancer patients: a randomized controlled clinical trial

por Hanai, Akiko, Ishiguro, Hiroshi, Sozu, Takashi, Tsuda, Moe, Arai, Hidenori, Mitani, Akira, Tsuboyama, Tadao
Publicado 2015

Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma

por Mu, Song, Kuroda, Yoshiaki, Shibayama, Hirohiko, Hino, Masayuki, Tajima, Takeshi, Corrado, Claudia, Lin, Rong, Waldron, Edward, Binlich, Florence, Suzuki, Kenshi
Publicado 2015

Efficacy of local application of an Unani formulation in acne vulgaris

por Sultana, Shabiya, Zulkifle, Mohd., Ansari, Abdul Haseeb, Shahnawaz
Publicado 2015

Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling

por Gregory, Walter M., Twelves, Christopher J., Bell, Richard, Smye, Stephen W., Howard, Dena R., Coleman, Robert E., Cameron, David A.
Publicado 2016

Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer: Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance

por Viale, Giuseppe, Slaets, Leen, de Snoo, Femke A., Bogaerts, Jan, Russo, Leila, van’t Veer, Laura, Rutgers, Emiel J. T., Piccart-Gebhart, Martine J., Stork-Sloots, Lisette, Dell’Orto, Patrizia, Glas, Annuska M., Cardoso, Fatima
Publicado 2016

Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study

por Jain, Minish M., Gupte, Smita U., Patil, Shekhar G., Pathak, Anand B., Deshmukh, Chetan D., Bhatt, Niraj, Haritha, Chiramana, Govind Babu, K., Bondarde, Shailesh A., Digumarti, Raghunadharao, Bajpai, Jyoti, Kumar, Ravi, Bakshi, Ashish V., Bhattacharya, Gouri Sankar, Patil, Poonam, Subramanian, Sundaram, Vaid, Ashok K., Desai, Chirag J., Khopade, Ajay, Chimote, Geetanjali, Bapsy, Poonamalle P., Bhowmik, Shravanti
Publicado 2016

Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trial

por Welt, A., Marschner, N., Lerchenmueller, C., Decker, T., Steffens, C.-C., Koehler, A., Depenbusch, R., Busies, S., Hegewisch-Becker, S.
Publicado 2016

Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative b...

por Martin, Miguel, Brase, Jan C., Ruiz, Amparo, Prat, Aleix, Kronenwett, Ralf, Calvo, Lourdes, Petry, Christoph, Bernard, Philip S., Ruiz-Borrego, Manuel, Weber, Karsten E., Rodriguez, César A., Alvarez, Isabel M., Segui, Miguel A., Perou, Charles M., Casas, Maribel, Carrasco, Eva, Caballero, Rosalía, Rodriguez-Lescure, Alvaro
Publicado 2016

Improved participants’ understanding in a healthy volunteer study using the SIDCER informed consent form: a randomized-controlled study

por Koonrungsesomboon, Nut, Teekachunhatean, Supanimit, Hanprasertpong, Nutthiya, Laothavorn, Junjira, Na-Bangchang, Kesara, Karbwang, Juntra
Publicado 2015

Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study

por van Roozendaal, Lori M., Smit, Leonie H. M., Duijsens, Gaston H. N. M., de Vries, Bart, Siesling, Sabine, Lobbes, Marc B. I., de Boer, Maaike, de Wilt, Johannes H. W., Smidt, Marjolein L.
Publicado 2016

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy

por van Roozendaal, L. M., Goorts, B., Klinkert, M., Keymeulen, K. B. M. I., De Vries, B., Strobbe, L. J. A., Wauters, C. A. P., van Riet, Y. E., Degreef, E., Rutgers, E. J. T., Wesseling, J., Smidt, M. L.
Publicado 2016

Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry

por Iwamoto, Takayuki, Kumamaru, Hiraku, Miyata, Hiroaki, Tomotaki, Ai, Niikura, Naoki, Kawai, Masaaki, Anan, Keisei, Hayashi, Naoki, Masuda, Shinobu, Tsugawa, Koichiro, Aogi, Kenjiro, Ishida, Takanori, Masuoka, Hideji, Iijima, Kotaro, Matsuoka, Junji, Doihara, Hiroyoshi, Kinoshita, Takayuki, Nakamura, Seigo, Tokuda, Yutaka
Publicado 2016

Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC‐ONC Study—A Single‐Center, Blinded, Randomized Controlled Trial

por Chung, Robin, Maulik, Angshuman, Hamarneh, Ashraf, Hochhauser, Daniel, Hausenloy, Derek J., Walker, J. Malcolm, Yellon, Derek M.
Publicado 2016

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation

por Song, Ivy, Weller, Steve, Patel, Juhin, Borland, Julie, Wynne, Brian, Choukour, Mike, Jerva, Fred, Piscitelli, Stephen
Publicado 2016

Prognostic impact of breast cancer subtypes in elderly patients

por Bergen, E. S., Tichy, C., Berghoff, A. S., Rudas, M., Dubsky, P., Bago-Horvath, Z., Mader, R. M., Exner, R., Gnant, M., Zielinski, C. C., Steger, G. G., Preusser, M., Bartsch, R.
Publicado 2016

Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance

por Inoue, Kenichi, Saito, Tsuyoshi, Okubo, Katsuhiko, Kimizuka, Kei, Yamada, Hirofumi, Sakurai, Takashi, Ishizuna, Kazuo, Hata, Satoshi, Kai, Toshihiro, Kurosumi, Masafumi
Publicado 2016

The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies

por Karakatsanis, Andreas, Christiansen, Peer Michael, Fischer, Lone, Hedin, Christina, Pistioli, Lida, Sund, Malin, Rasmussen, Nils Ryegaard, Jørnsgård, Hjørdis, Tegnelius, Daniel, Eriksson, Staffan, Daskalakis, Kosmas, Wärnberg, Fredrik, Markopoulos, Christos J., Bergkvist, Leif
Publicado 2016